Based on the above analysis, we proposed a hypothesis that PSMD14 is activated by MEF2A transcription, which upregulates SPON2 expression in an m6A‐RBM15B‐dependent manner, ultimately promoting PC progression. The gene discussed is PSMD14; the disease is pachyonychia congenita.